Isolation of a peptide from Ph.D.-C7C phage display library for detection of Cry1Ab

Binding Peptide-Promoted Biofunctionalization of Graphene Paper with Hydroxyapatite for Stimulating Osteogenic Differentiation of Mesenchymal Stem Cells

Graphene paper (GP), a macroscopic self-supporting material, has exceptional flexibility and preserves the excellent physical and chemical properties of graphene nanomaterials. But its applications in regenerative medicine remain to be further explored. Here, we biologically functionalized GP with hydroxyapatite (HA) nanorods by the use of GP-binding peptides as an affinity linker. This strategy solved two daunting challenges for regenerative medicine applications of GP: the lack of good hydrophilicity for supporting cell growth and the difficulty in forming composites by binding with nanobiomaterials. Briefly, we first screened a high-affinity GP-binding peptide (TWWNPRLVYFDY) by the phage display technique. Then we chemically conjugated the GP-binding peptide to the synthetic HA nanorods. The GP-binding peptide on the resultant HA nanorods enabled them to be bound and assembled onto the GP substrate with high affinity, forming a GP-peptide-HA composite with significantly improved hydrophilicity of GP. The composite promoted the attachment and proliferation of mesenchymal stem cells (MSCs), demonstrating its outstanding biocompatibility. Due to the unique compositions of the composite, it was also found to induce osteogenic differentiation of MSCs in vitro in the absence of other inducers in the medium, by verifying the expression of the osteogenic markers including collagen-1, bone morphogenetic proteins 2, runx-related transcription factor 2, osteocalcin, and alkaline phosphatase. Our work suggests that the GP-binding peptide can be used to link inorganic nanoparticles onto GP to facilitate the biomedical applications of GP.

Quantification of silk protein using phage nanofibers with high binding specificity

Silk sericin (SS) has emerged as an important silk protein for use in medicine and textiles. However, no sensitive method is available for detecting it. Here, we employed phage nanofibers (∼7 nm wide) as a probe to quantify SS from a dilute aqueous solution by exploiting two properties of the bacteria-infecting phage nanofibers, its use as a platform for discovering SS-binding peptide and its ultrasensitive quantification by a simple titering assay (where the number of phage nanofibers displaying the SS-binding peptide is equal to the number of countable millimeter-sized plaques derived from the phage nanofibers by infecting bacteria through plating). We first discovered a SS-binding peptide and the phage nanofibers (SS-phage) displaying this peptide at the tip. We found that this peptide can even differentiate SS from another silk protein (silk fibroin), showing its high specificity. We then employed SS-phage nanofibers as a probe to bind the SS casted from the aqueous solution. Because SS-phage nanofibers bound to the SS and the SS in the original SS solution were numerically correlated and the number of SS-phage nanofibers can be determined by counting the plaques in a Petri dish by the titering assay, determining the number of phage-derived plaques with the naked eye led to the rapid quantification of SS concentration with a detection limit of 19.50 ng ml^-1. This phage-based counting strategy can be potentially applied to the facile detection of other proteins.

Atom transfer radical polymer-modified paper for improvement in protein fixation in paper-based ELISA

A newly modified paper-based enzyme-linked immunosorbent assay (P-ELISA) was established by immobilizing more proteins on the paper surface through an atom transfer radical polymerization (ATRP) reaction. In addition, introducing graphene oxide (GO) sheets, Au nanoparticles (AuNps) and two primary antibodies (Ab1s) led to signal amplification and cost reduction.

Virus-Derived Peptides for Clinical Applications

Novel affinity agents with high specificity are needed to make progress in disease diagnosis and therapy. Over the last several years, peptides have been considered to have fundamental benefits over other affinity agents, such as antibodies, due to their fast blood clearance, low immunogenicity, rapid tissue penetration, and reproducible chemical synthesis. These features make peptides ideal affinity agents for applications in disease diagnostics and therapeutics for a wide variety of afflictions. Virus-derived peptide techniques provide a rapid, robust, and high-throughput way to identify organism-targeting peptides with high affinity and selectivity. Here, we will review viral peptide display techniques, how these techniques have been utilized to select new organism-targeting peptides, and their numerous biomedical applications with an emphasis on targeted imaging, diagnosis, and therapeutic techniques. In the future, these virus-derived peptides may be used as common diagnosis and therapeutics tools in local clinics.